Skip to main content

This webpage content is intended for Health Care Professionals (HCP’s) only.

I am not a HCP

Intended for Healthcare Professionals

Johnson and Johnson logo graphic link
/en-EMEA
  • biosense webster logo
  • Cerenovus JJMT logo
  • DePuy Synthes Logo
  • Ethicon Logo
  • mentor logo

Intended for HCPs

Intended for Healthcare Professionals

Secondary nav block

logo_test
  • Home
  • About Us
    • About J&J MedTech
    • Careers
    • Investors
    • Our Companies
  • Our Impact
    • Submit Medical Information Request
    • HCP Education
    • Our Societal Impact
  • Our Solutions
    • Digital Health Technology Consultants & Innovations
    • Surgical Excellence
    • Patient Pathway
    • Operating Room Optimization
    • Hospital Logistics
    • Financing Solutions
  • News
  • Contact

News & Events

Biosense Webster Logo

Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial

07 March 2023
Julie Brooker, MD Janssen Denmark; Henning Langberg, CIO Rigshospitalet; Sven Dohmann, Country Director, J&J MedTech Denmark.

Why Johnson & Johnson MedTech and Janssen are Partnering with Denmark’s Largest University Hospital

29 November 2022
Breast Cancer Awareness Month banner with cartoon women

Breast Cancer Awareness Month

02 November 2022
kevin hall selfie with significant other

What Kevin Hall wants everyone to know about Atrial fibrillation.

01 November 2022
Biosense Webster Launches HELIOSTAR™ in Europe

Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

12 October 2022
Patrick Brouwer, and 3 colleagues in the lab in white coats

The Neuro Thromboembolic Initiative: Addressing the science behind clots.

07 October 2022
Mahmood Mirza and 4 colleagues in the lab in white coats and masks.

Stroke Science: From Lab to Life. “As research engineers we are inspired by the challenge of enabling physicians to give patients the best possible clinical outcome.”

28 September 2022
biosense webster logo

Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology

06 September 2022
MedTech Forum

JJMT Leads The Conversation On Data Governance and Innovation At MedTech Forum 2022

16 May 2022
EMBOTRAP BANNER

New research shows first pass recanalization in mechanical thrombectomy could deliver environmental benefits whilst improving patient outcomes.

14 April 2022
  • Load More
Johnson and Johnson logo
Johnson & Johnson
  • Privacy Policy
  • Legal Notice
  • Careers
  • J&J Institute
  • Contact
  • Accessibility Statement
  • Cookie Policy
English (EMEA)

All contents © Medical Devices Business Services, Inc. 2021. All Rights Reserved

You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.

Yes, Continue to External Site No, Stay Here